Sponsor
Celica d.o.o.
Tehnoloski Park 24, 1000 Ljubljana, Slovenia
About the sponsor
Clinical research activity is centered on triple negative breast cancer, with attention to disease management in stage II and stage III settings. The sponsor’s trial portfolio is focused on an aggressive breast cancer subtype that lacks common hormone and receptor targets.
- Oncology
- Breast cancer
- Triple negative disease
Research activity in this area reflects interest in clinically relevant treatment options for patients with limited targeted therapeutic pathways.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.